Cori Gorman

Chief Executive Officer at BioXpress Therapeutics SA

Commercial Services

Health Technology

Profile

Cori Gorman is currently the Chairman and CEO of BioXpress Therapeutics SA, a position she has held since 2010.
Prior to this, she worked as the Vice President of Business Development at Selexis SA.

Cori Gorman active positions

Companies	Position	Start
BioXpress Therapeutics SA BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland.	Chief Executive Officer	2010-06-30

All active positions of Cori Gorman

Former positions of Cori Gorman

Companies	Position	End
Selexis SA Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland.	Corporate Officer/Principal	-

See the detail of Cori Gorman's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cori Gorman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Selexis SA Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland.	Commercial Services
BioXpress Therapeutics SA BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland.	Health Technology